Breaking News Instant updates and real-time market news.

FSLR

First Solar

$48.43

1.6 (3.42%)

, HSIC

Henry Schein

$161.15

-7.73 (-4.58%)

09:55
09/15/17
09/15
09:55
09/15/17
09:55

Early notable gainers among liquid option names on September 15th

Notable gainers among liquid option names this morning include First Solar (FSLR) $51.04 +2.60, Henry Schein (HSIC) $84.15 +3.56, NVIDIA (NVDA) $176.09 +6.69, Dentsply Sirona (XRAY) $59.26 +1.14, and Patterson Companies (PDCO) $38.89 +0.67.

FSLR

First Solar

$48.43

1.6 (3.42%)

HSIC

Henry Schein

$161.15

-7.73 (-4.58%)

NVDA

Nvidia

$169.40

-0.97 (-0.57%)

XRAY

Dentsply Sirona

$58.12

-1.02 (-1.72%)

PDCO

Patterson Companies

$38.23

-1.21 (-3.07%)

  • 18

    Sep

  • 19

    Sep

  • 27

    Sep

FSLR First Solar
$48.43

1.6 (3.42%)

08/24/17
AXIO
08/24/17
NO CHANGE
AXIO
JA Solar likely to report Q3 loss, says Axiom
Axiom analyst Gordon L Johnson III says his recent checks indicate that China and global prices for modules and cell dropped slightly last week, while spot prices for polysilicon and multi wafers used to make solar modules and cells rose sharply from July 12 to August 9 and have since been stable. As a result, the analyst calculates that companies which bought the raw materials at spot prices have seen their margins on solar cells fall to a record low -12.9%, while module makers who bought the raw materials at spot prices have margins of -3.7%, the lowest level since Axiom began tracking them. Given these trends, Johnson predicts that JA Solar will report a Q3 pretax loss of $10M and warns that the company's results could deteriorate further in Q4. Other publicly traded companies in the space include Canadian Solar (CSIQ), First Solar (FSLR), SunEdison (SUNEQ), SunPower (SPWR), Trina Solar (TSL) and Yingli Green Energy (YGE).
08/16/17
JMPS
08/16/17
NO CHANGE
JMPS
First Solar price target raised to $67 from $53 at JMP Securities
JMP Securities analyst Joseph Osha raised his price target on First Solar after attending a U.S. International Trade Commission hearing on the Section 201 petition. The analyst now believes there is a 75% chance of the commission determining that an injury has been committed, up from 50% previously. He keeps an Outperform rating on the stock.
09/15/17
DBAB
09/15/17
UPGRADE
Target $65
DBAB
Buy
First Solar upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Vishal Shah upgraded First Solar to Buy and raised his price target for the shares to $65 from $50. The provider of photovoltaic solar energy solutions closed yesterday up $1.60 to $48.43. Channel checks indicate that "robust" U.S. demand is driving module prices higher, Shah tells investors in a research note. He believes First Solor is likely to announce additional 1GW of series 4 capacity extension for next year as well as orders for series 6 modules sooner than most investors expect. He sees upside to near-term estimates for the company.
07/28/17
COWN
07/28/17
NO CHANGE
Target $57
COWN
Outperform
First Solar price target raised to $57 from $52 at Cowen
Cowen analyst Jeffrey Osborne raised his price target on First Solar to $57 from $52 following Q2 results. The analyst cited the Section 201 ruling that has led to an increase in U.S. prices, which could favor the 300-500MW of remaining Series 4 supply. Long-term earnings power stems from Series 6, which is on track for production in 2018, said Osborne, who reiterated his Outperform rating on First Solar.
HSIC Henry Schein
$161.15

-7.73 (-4.58%)

08/29/17
UBSW
08/29/17
NO CHANGE
Target $204
UBSW
Buy
Henry Schein remains attractive following acquisition, says UBS
UBS analyst Michael Cherny noted Henry Schein announced it would acquire Merritt Veterinary Supplies, which he said remains consistent with the company's core growth strategy of supplementing organic growth with complementary tuck-in M&A. Cherny continues to see Henry Schein shares as attractive and reiterated his Buy rating and $204 price target.
09/13/17
STFL
09/13/17
NO CHANGE
STFL
Online trend continues as risk in dental consumables, says Stifel
Stifel analyst Jonathan Block said his survey of 106 dental practices showed that online vendors are gaining traction, and this trend is expected to continue. 39% of respondents currently use an online vendor such as Amazon (AMZN) for 21% of their dental consumables and traction among current users is expected to climb higher while additional practices plan to start using an online vendor, noted Block, who views this trend as a long-term headwind for Patterson Companies (PDCO) and Henry Schein (HSIC). In the Dental space, he keeps a Buy rating on Dentsply Sirona (XRAY), a Hold on Henry Schein, and a Sell on Patterson.
09/15/17
PIPR
09/15/17
UPGRADE
Target $193
PIPR
Overweight
Henry Schein upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Sarah James upgraded Henry Schein (HSIC) to Overweight and raised his price target for the shares to $193 from $190. The analyst believes concern over Amazon (AMZN) entering the market is overdone and sees potential for improvement in dental consumables based on her firm's consumer surveys. James believes the recent pullback in Henry Schein shares creates an attractive entry point. She calls the company a "high quality, low earnings risk name."
09/15/17
UBSW
09/15/17
NO CHANGE
Target $204
UBSW
Buy
Henry Schein shares have been overly penalized, says UBS
UBS analyst Michael Cherny said a recent virtual presentation by Henry Schein continued to highlight its value proposition of its broad service offerings and highlighted its own capabilities around e-commerce. He said the company remains optimistic about the dental market and he feels the stock has been overly penalized due to industry headwinds. Cherny reiterated his Buy rating and $204 price target on Henry Schein shares.
NVDA Nvidia
$169.40

-0.97 (-0.57%)

09/15/17
EVER
09/15/17
NO CHANGE
Target $250
EVER
Outperform
Nvidia price target raised to $250 from $180 at Evercore ISI
After meeting with Nvidia's CEO and CFO, Evercore ISI analyst C.J. Muse said management believes that investors still severely underestimate the impact of Artificial Intelligence and the size of the potential AI market. Meanwhile, he contends that NVIDIA is creating "THE AI computing industry standard" that will be "nearly impossible to replicate." Led by AI in the Data Center and Automotive markets, he sees Nvidia having a clear path to $10 in EPS over the next 3-5 years and raised his price target on the stock to $250 from $180. Muse keeps an Outperform rating on Nvidia shares.
09/11/17
JEFF
09/11/17
NO CHANGE
JEFF
Jefferies lays out cryptocurrency exposure at Nvidia, AMD
Jefferies analyst Mark Lipacis estimates that in Q2, cryptocurrency revenues accounted for about 3% of quarterly sales for AMD (AMD) and about 10% for Nvidia (NVDA). The risk of a "crypto-driven" inventory correction driving material downside is low in the near term, Lipacis tells investors in a research note. He points out that cryptocurrency prices "increased materially" since bottoming in July. Further, both companies have introduced "cryptospecific GPU SKUs" that have a low risk of competing with core gaming GPUs in secondary markets, Lipacis writes. The analyst does not think cryptocurrencies are Fad. The technology they are based on, called Blockchain, supports secure accounting of distributed ledgers and has applications in financial services beyond cryptocurrencies, the analyst argues.
08/24/17
RBCM
08/24/17
NO CHANGE
RBCM
Demand for Nvidia gaming chips remains strong, says RBC Capital
After conducting checks and reviewing Nvidia's (NVDA) 10-Q, RBC Capital analysts Mitch Steves and Amit Daryanani say that demand for Nvidia's gaming chips "remains healthy" in the midst of strong demand from crypto-currency miners. The analysts add that the company's new deal with Toyota (TM) should boost its selling volumes in 2018-2019, and cause its average selling prices to rise towards the end of that period. They add that sales of the company's Volta chip "are beginning to ramp." The analysts keep an Outperform rating on Nvidia.
08/14/17
ARGS
08/14/17
NO CHANGE
ARGS
Nvidia weakness a buying opportunity, says Argus
Argus analyst Jim Kelleher,says the decline in Nvidia's stock following its results was a "nonfundamental selloff." Calling Nvidia a "leading silicon play on AI, autonomous vehicles, machine learning, and next-generation data center," he recommends buying the shares on weakness.
XRAY Dentsply Sirona
$58.12

-1.02 (-1.72%)

07/26/17
GSCO
07/26/17
NO CHANGE
GSCO
Dental survey indicates Q2 upside for Align, Henry Schein, says Goldman Sachs
Goldman analyst Robert Jones said checks indicate Q2 Dental trends remained stable and point to consistent low-single-digit growth end-markets. The analyst likes Align Technology (ALGN) saying Q2 case guidance appears beatable and expects high 20% case growth driven by investments, sees Q2 upside for Henry Schein (HSIC) due to share gains from Patterson Companies (PDCO), and said Dentsply Sirona (XRAY) promotions to drive cross-selling have yet to gain traction and 2017 guidance may be aggressive, but expectations are low into the quarter.
08/01/17
NRCS
08/01/17
NO CHANGE
Target $76
NRCS
Buy
Dentsply Sirona estimaters reduced at Northcoast
Northcoast analyst Ed Snyder's checks indicate Patterson Companies (PDCO) sales of high technology dental equipment is weaker than expected caused by industry competition. Snyder said it appears Patterson's CEREC sales growth is down about 40-50%, despite promotional activity. As a result, he reduced Dentsply Sirona's (XRAY) second half internal growth estimate to 1.4% from 2.3% and earnings FY17 earnings estimate to $2.80 from $2.82. Snyder retains a Buy rating on Dentsply and a $76 price target.
08/25/17
UBSW
08/25/17
UPGRADE
Target $40
UBSW
Neutral
Patterson Companies upgraded to Neutral from Sell at UBS
UBS analyst Michael Cherny upgraded Patterson Companies (PDCO) to Neutral from Sell, stating that his sell thesis played out more quickly than he anticipated. His call was the risk to out-year estimates as the company worked to transition away from its exclusive Sirona (XRAY) relationship in the U.S. Although he still has concerns over the growth rebound, he feels the risk/reward is more balanced. Cherny has a $40 price target on Patterson Companies shares.
PDCO Patterson Companies
$38.23

-1.21 (-3.07%)

08/17/17
CHLM
08/17/17
NO CHANGE
Target $41
CHLM
Hold
Patterson Companies price target lowered to $41 from $46 at Craig-Hallum
Craig-Hallum analyst Kevin Ellich lowered his price target for Patterson Companies(PDCO) to $41 from $46 to reflect the soft dental consumable environment and potential market share losses once Henry Schein (HSIC) starts to sell CEREC on September 1. Given the lower valuation and good, stable end markets, the analyst thinks Patterson Companies could be an "interesting target" for a financial buyer as cash flow should start to improve over the next few quarters once the company completes the ERP implementation. He reiterates a Hold rating on Patterson Companies' shares.
08/22/17
CLVD
08/22/17
NO CHANGE
CLVD
Neutral
Patterson Companies fundamentals remain soft, says Cleveland Research
Cleveland Research analyst Rob Eich said Patterson Companies fundamentals remain soft due to salesforce execution and morale, management attrition and turnover, CEREC end-user sales seem to gotten incrementally worse, and execution appears to have been negatively impacted by CEREC distribution change and SAP implementation. The analyst sees risk to FY18 consensus estimates and maintains a Neutral rating.

TODAY'S FREE FLY STORIES

CENT

Central Garden & Pet

$37.82

0.09 (0.24%)

20:37
01/22/18
01/22
20:37
01/22/18
20:37
Upgrade
Central Garden & Pet rating change  »

Central Garden & Pet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPAR

Inter Parfums

$45.90

-1.9 (-3.97%)

20:33
01/22/18
01/22
20:33
01/22/18
20:33
Downgrade
Inter Parfums rating change  »

Inter Parfums downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$148.14

0.78 (0.53%)

, PG

Procter & Gamble

$91.89

0.82 (0.90%)

20:25
01/22/18
01/22
20:25
01/22/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

JNJ

Johnson & Johnson

$148.14

0.78 (0.53%)

PG

Procter & Gamble

$91.89

0.82 (0.90%)

VZ

Verizon

$53.46

1.55 (2.99%)

KMB

Kimberly-Clark

$116.91

1.42 (1.23%)

TRV

Travelers

$139.35

1.5 (1.09%)

FITB

Fifth Third

$32.77

0.27 (0.83%)

HBAN

Huntington Bancshares

$16.03

0.22 (1.39%)

WAT

Waters

$214.77

4.05 (1.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 25

    Jan

  • 06

    Feb

  • 13

    Feb

  • 16

    Feb

  • 08

    Mar

SSNLF

Samsung

19:26
01/22/18
01/22
19:26
01/22/18
19:26
Hot Stocks
Samsung says new tariff 'great loss' for American consumers, workers »

In reaction to a final…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

FTK

Flotek

$5.71

0.07 (1.24%)

19:23
01/22/18
01/22
19:23
01/22/18
19:23
Hot Stocks
Flotek expands lines of chemistry technologies »

Flotek Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

ACLS

Axcelis

19:22
01/22/18
01/22
19:22
01/22/18
19:22
Upgrade
Axcelis rating change  »

Axcelis upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$90.64

2.8 (3.19%)

19:22
01/22/18
01/22
19:22
01/22/18
19:22
Downgrade
Wayfair rating change  »

Wayfair downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

EPE

EP Energy

$2.48

0.17 (7.36%)

19:00
01/22/18
01/22
19:00
01/22/18
19:00
Conference/Events
EP Energy to hold a conference call »

Management discusses its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

BRSS

Global Brass and Copper

$33.30

-0.55 (-1.62%)

18:47
01/22/18
01/22
18:47
01/22/18
18:47
Hot Stocks
Global Brass and Copper reports oil spill at Somers Thin Strip plant »

Somers Thin Strip, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$227.58

7.12 (3.23%)

, DIS

Disney

$111.10

0.51 (0.46%)

18:38
01/22/18
01/22
18:38
01/22/18
18:38
Hot Stocks
Netflix doesn't see Disney-Fox deal as a direct threat »

Says Disney (DIS) and Fox…

NFLX

Netflix

$227.58

7.12 (3.23%)

DIS

Disney

$111.10

0.51 (0.46%)

FOX

21st Century Fox

$36.96

0.7 (1.93%)

FOXA

21st Century Fox

$37.31

0.66 (1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 30

    Jan

  • 06

    Feb

  • 07

    Feb

  • 07

    Feb

T

AT&T

$37.87

0.66 (1.77%)

, TWX

Time Warner

$94.00

0.64 (0.69%)

18:37
01/22/18
01/22
18:37
01/22/18
18:37
Periodicals
Judge orders DOJ to seek consent to give data to AT&T, Time Warner, Reuters says »

Judge Richard Leon, who…

T

AT&T

$37.87

0.66 (1.77%)

TWX

Time Warner

$94.00

0.64 (0.69%)

DIS

Disney

$111.10

0.51 (0.46%)

FOX

21st Century Fox

$36.96

0.7 (1.93%)

FOXA

21st Century Fox

$37.31

0.66 (1.80%)

VIA

Viacom

$39.30

0.1 (0.26%)

VIAB

Viacom

$33.94

0.58 (1.74%)

DISCA

Discovery

$26.33

0.62 (2.41%)

SNI

Scripps Networks

$88.77

0.27 (0.31%)

CMCSA

Comcast

$42.89

0.39 (0.92%)

CMCSK

Comcast

CHTR

Charter

$370.25

4.2 (1.15%)

ATUS

Altice USA

$21.90

0.6 (2.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 31

    Jan

  • 02

    Feb

  • 06

    Feb

  • 07

    Feb

  • 07

    Feb

  • 08

    Feb

  • 08

    Feb

  • 12

    Feb

  • 27

    Feb

NFLX

Netflix

$227.58

7.12 (3.23%)

18:25
01/22/18
01/22
18:25
01/22/18
18:25
Hot Stocks
Netflix says it has a ways to go to hit 60M U.S. subscribers »

Says has a ways to go to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 30

    Jan

BIVV

Bioverativ

$103.79

39.68 (61.89%)

, SNY

Sanofi

$43.20

-1.4 (-3.14%)

18:15
01/22/18
01/22
18:15
01/22/18
18:15
Downgrade
Bioverativ, Sanofi rating change at Jefferies »

Bioverativ downgraded to…

BIVV

Bioverativ

$103.79

39.68 (61.89%)

SNY

Sanofi

$43.20

-1.4 (-3.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 14

    Feb

  • 16

    Feb

  • 08

    Mar

  • 25

    Mar

  • 25

    Apr

  • 02

    May

ECR

Eclipse Resources

$2.33

0.05 (2.19%)

18:12
01/22/18
01/22
18:12
01/22/18
18:12
Conference/Events
Eclipse Resources to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$227.58

7.12 (3.23%)

18:10
01/22/18
01/22
18:10
01/22/18
18:10
Hot Stocks
Netflix says Asia market projects 'well' »

Says very pleased with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 30

    Jan

STLD

Steel Dynamics

$46.57

0.15 (0.32%)

18:06
01/22/18
01/22
18:06
01/22/18
18:06
Hot Stocks
Steel Dynamics CEO says domestic inventory levels moderated »

Steel Dynamics CEO Mark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

STLD

Steel Dynamics

$46.57

0.15 (0.32%)

18:04
01/22/18
01/22
18:04
01/22/18
18:04
Earnings
Steel Dynamics reports Q4 EPS 54c excluding items, consensus 52c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

IMI

Intermolecular

$1.61

0.14 (9.52%)

18:02
01/22/18
01/22
18:02
01/22/18
18:02
Hot Stocks
Intermolecular and SITRI expand alliance to address Chinese market »

Intermolecular and SITRI…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

EXFO

EXFO Inc.

$4.35

-0.05 (-1.14%)

, CHL

China Mobile

$51.97

0.45 (0.87%)

18:01
01/22/18
01/22
18:01
01/22/18
18:01
Hot Stocks
EXFO partners with China Mobile to prepare network for IoT »

EXFO Inc. (EXFO)…

EXFO

EXFO Inc.

$4.35

-0.05 (-1.14%)

CHL

China Mobile

$51.97

0.45 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$111.12

-1.84 (-1.63%)

18:00
01/22/18
01/22
18:00
01/22/18
18:00
Hot Stocks
Celanese announces acetyl intermediates price increases »

Celanese Corporation will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jan

SFNC

Simmons First National

$59.50

0.35 (0.59%)

18:00
01/22/18
01/22
18:00
01/22/18
18:00
Earnings
Simmons First National reports Q4 core EPS 97c, consensus 88c »

Reports Q4 core net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

WHR

Whirlpool

$166.65

-0.88 (-0.53%)

, SSNLF

Samsung

17:59
01/22/18
01/22
17:59
01/22/18
17:59
Hot Stocks
Whirlpool chairman praises Trump's move to establish tariff on washing machines »

Whirlpool (WHR) chairman…

WHR

Whirlpool

$166.65

-0.88 (-0.53%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 30

    Jan

AMBC

Ambac Financial

$16.02

0.07 (0.44%)

17:48
01/22/18
01/22
17:48
01/22/18
17:48
Hot Stocks
Ambac Financial announces approval of plan amendment »

Ambac Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STML

Stemline

$14.25

0.7 (5.17%)

17:47
01/22/18
01/22
17:47
01/22/18
17:47
Conference/Events
Stemline participates in a conference call with JPMorgan »

Investor conference call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

EFSC

Enterprise Financial

$47.70

-0.025 (-0.05%)

17:42
01/22/18
01/22
17:42
01/22/18
17:42
Earnings
Enterprise Financial reports Q4 EPS 77c, consensus 77c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.